NCT02473705

Brief Summary

The purpose of this research study is to study the effect of fish oil and bicarbonate (baking soda) on exercise. In this study fish oil, bicarbonate or both will be compared to placebo to see if study participants increase exercise capacity.

Trial Health

30
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Timeline
Completed

Started Jan 2016

Geographic Reach
1 country

1 active site

Status
withdrawn

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 10, 2015

Completed
6 days until next milestone

First Posted

Study publicly available on registry

June 16, 2015

Completed
7 months until next milestone

Study Start

First participant enrolled

January 1, 2016

Completed
1.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2017

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2017

Completed
Last Updated

November 7, 2017

Status Verified

September 1, 2016

Enrollment Period

1.4 years

First QC Date

June 10, 2015

Last Update Submit

November 3, 2017

Conditions

Keywords

Geriatricbicarbonateomega polyunsaturated fatty acidsexercise capacity

Outcome Measures

Primary Outcomes (1)

  • Change from Baseline of VO2 peak at 12 weeks

    Treadmill during a graded exercise test to exhaustion using a Ramp protocol

    12 weeks

Study Arms (4)

Fish Oil and Bicarbonate placebo

ACTIVE COMPARATOR

1280mg of fish oil per day and bicarbonate placebo

Dietary Supplement: Fish Oil and Bicarbonate Placebo

Fish Oil Placebo and Bicarbonate

ACTIVE COMPARATOR

fish oil placebo and 1mg of bicarbonate per Kg of body weight per day

Dietary Supplement: Fish Oil Placebo and Bicarbonate

Fish Oil and Bicarbonate

EXPERIMENTAL

1280mg of fish oil per day and 1mg of bicarbonate per Kg of body weight per day

Dietary Supplement: Fish Oil and Bicarbonate

Fish Oil placebo and Bicarbonate placebo

PLACEBO COMPARATOR

Fish oil placebo and Bicarbonate placebo

Dietary Supplement: Fish Oil Placebo and Bicarbonate Placebo

Interventions

Fish Oil and BicarbonateDIETARY_SUPPLEMENT

1280mg of fish oil per day and 1mg of bicarbonate per Kg of body weight per day

Also known as: Nordic Naturals - Ultimate Omega
Fish Oil and Bicarbonate

1280mg of fish oil per day and bicarbonate placebo (Methylcellulose)

Also known as: Nordic Naturals - Ultimate Omega
Fish Oil and Bicarbonate placebo

Fish oil placebo (soybean oil) and 1mg of bicarbonate per Kg of body weight per day

Fish Oil Placebo and Bicarbonate

Fish oil placebo (soybean oil) and bicarbonate placebo (Methylcellulose)

Fish Oil placebo and Bicarbonate placebo

Eligibility Criteria

Age60 Years - 90 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Referred to Cardiac Rehabilitation after acute coronary syndromes or percutaneous intervention
  • Stage III Chronic kidney disease
  • Clinically stable with no mobility conditions that preclude safe walking and able to walk
  • No contraindications that will prevent measurement of physical ability and exercise capacity including severe arthritis or musculoskeletal disorders
  • knee/hip replacement or spinal surgery in past year
  • Approved for participation by Principal Investigator
  • Not involved in any other research study or undergoing physical therapy
  • Able to provide own transportation to study visits and intervention
  • Willing to provide written consent

You may not qualify if:

  • Currently taking fish oil supplements
  • Advanced malignancy or other medical condition with life expectancy less than 2 years or undergoing active chemotherapy or radiation therapy
  • Oxygen-dependent chronic obstructive pulmonary disease
  • Normal kidney function or advanced chronic kidney disease (glomerular filtration rate \< 20 mL/min/1.73 m2, on dialysis or dialysis anticipated within 6 months)
  • Mini-mental state examination score of ≤ 21 or previously diagnosed dementia or cognitive impairment limiting ability to participate in rehabilitation and follow study protocols
  • Chronic anemia with hemoglobin \<10 gm/dl for males, \<9 gm/dl for females or acute anemia requiring transfusion
  • Significant impairment from a prior stroke or other neurologic disease or injury that would preclude participation
  • Severe peripheral arterial disease that is the primary limitation to ambulation
  • Medical condition that would limit exercise
  • High risk for non-adherence as determined by screening evaluation
  • Patients who have undergone renal transplantation
  • Currently taking bicarbonate supplementation
  • Current or recent (within the last 3 months) participation in an exercise program
  • Carbon Dioxide level greater than the middle of the normal range i.e. 27mmol/L and thus predisposing to metabolic alkalosis
  • Moderate 2+ or greater lower extremity edema
  • +3 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Wake Forest Baptist Health Cardiac Rehab

Winston-Salem, North Carolina, 27157, United States

Location

MeSH Terms

Conditions

Renal Insufficiency, ChronicCardiovascular Diseases

Interventions

Fish OilsBicarbonates

Condition Hierarchy (Ancestors)

Renal InsufficiencyKidney DiseasesUrologic DiseasesFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesMale Urogenital DiseasesChronic DiseaseDisease AttributesPathologic ProcessesPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

OilsLipidsCarbonatesCarbonic AcidCarbon Compounds, InorganicInorganic ChemicalsAnionsIonsElectrolytes

Study Officials

  • Killian Robinson, MD

    Wake Forest University Health Sciences

    PRINCIPAL INVESTIGATOR
0

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
PREVENTION
Intervention Model
FACTORIAL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 10, 2015

First Posted

June 16, 2015

Study Start

January 1, 2016

Primary Completion

June 1, 2017

Study Completion

June 1, 2017

Last Updated

November 7, 2017

Record last verified: 2016-09

Locations